Streetbeat News

Stock Prices

ARMP

Armata Pharmaceuticals (AMEX:ARMP) reported a Q3 EPS loss of $(0.86), significantly missing the $(0.31) estimate, representing a 258.33% increase in losses year-over-year. However, sales of $1.23M exceeded expectations by 28.95%, despite being an 8.45% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:05 pm

MAQC

Maquia Capital Acquisition Corporation (NASDAQ:MAQC), a SPAC, has filed a registration statement with the SEC for a proposed business combination with Immersed Inc., a provider of enterprise AI productivity solutions. The combined entity will be named 'Immersed Inc.' and will list on Nasdaq under the ticker 'AIMR'. Immersed has over 730,000 unique users and users spent 20 million minutes on its application in Q3 2023. The deal sets Immersed's pre-money enterprise value at $150 million and is expected to close in the first half of 2024, subject to approvals.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:03 pm

DNMR

Danimer Scientific (NYSE:DNMR) reported a Q3 EPS loss of $(0.39), an improvement from $(0.94) last year, but missed sales estimates with $10.95M compared to the expected $14.74M. Sales increased by 4.79% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:03 pm

IZEA

IZEA Worldwide reported Q3 earnings with a loss of $0.13 per share, significantly missing the consensus estimate of a $0.07 loss per share. This represents a 225% increase in losses compared to the same period last year. Quarterly sales were $7.89M, falling short of the expected $8.50M, and marking a 27.07% decrease from the previous year's sales.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:02 pm

CVX

Chevron (NYSE:CVX) has received 13 analyst ratings in the last quarter with an average price target of $193.92, which is significantly higher than its current price of $144.45. The ratings include 5 bullish, 3 somewhat bullish, and 5 indifferent, with no bearish ratings. The current average price target has decreased by 2.24% from the previous target of $198.36.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 9:00 pm

GTBIF

MRMD

TLLTF

VRNOF

Zuanic & Associates released reports on Verano Holdings, TILT Holdings, MariMed Inc., and Green Thumb Industries, analyzing their Q3 results and future outlook. Verano anticipates a 4Q decline due to various factors but shows positive cash flow trends. TILT exceeded 3Q expectations and is positioned for growth with new partnerships. MariMed's 4Q guidance is reduced due to expansion delays but has a positive outlook for CY24. Green Thumb's 3Q update lacks sales guidance for 4Q, but increased capital expenditures may boost 1H24 growth.

Portfolio Pulse from Nicolás Jose Rodriguez

November 14, 2023 | 8:58 pm

TGT

Target Corp (NYSE:TGT) is set to report Q3 earnings with an expected EPS of $1.48 and revenue of $25.31 billion. BofA analysts see modest downside risks due to inflation and macro challenges but maintain a Buy rating with a $135 price target. Target's stock has declined 36% over the past year, but improving margins and a low forward price multiple present a buy opportunity. Analysts will focus on macro headwinds and margin improvements in the earnings call.

Portfolio Pulse from Surbhi Jain

November 14, 2023 | 8:54 pm

ADV

AMCX

ATUS

ROKU

TTD

Shares of companies in the communication, media, and entertainment sectors are up due to positive market sentiment following October's softer-than-expected inflation data. This data suggests there may be less need for aggressive interest rate hikes by the Federal Reserve.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 8:54 pm

BRFS

BUD

DLTR

ELF

ENR

FMX

TGT

TSN

WALD

WBA

Consumer staples stocks are up due to market strength following October's inflation data, which was less severe than anticipated.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 8:52 pm